- Home
- XLO vs DTST Comparison
XLO vs DTST Comparison
Compare XLO & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XLO | DTST |
|---|---|---|
| Founded | 2016 | 2001 |
| Country | United States | United States |
| Employees | N/A | 55 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 37.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | XLO | DTST |
|---|---|---|
| Price | $0.65 | $5.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 528.0K | 134.9K |
| Earning Date | 11-13-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8036.56 |
| EPS | N/A | ★ 1.89 |
| Revenue | ★ $31,804,000.00 | $25,529,819.00 |
| Revenue This Year | $589.60 | N/A |
| Revenue Next Year | $38.00 | N/A |
| P/E Ratio | ★ N/A | $2.65 |
| Revenue Growth | ★ 588.40 | 260.19 |
| 52 Week Low | $0.62 | $2.93 |
| 52 Week High | $1.70 | $5.44 |
Technical Indicators
Market Signals| Indicator | XLO | DTST |
|---|---|---|
| Relative Strength Index (RSI) | 32.82 | 77.39 |
| Support Level | $0.68 | $4.93 |
| Resistance Level | $0.73 | $5.05 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 10.24 | 96.14 |
Price Performance
Historical ComparisonAbout XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.